Latest Breaking News On - Michaelh davidson - Page 1 : comparemela.com

NanoPhoria appoints Dr Suman Shirodkar as Chair and Prof Michael Davidson as Non-Executive Member of the Board of Directors

NanoPhoria appoints Dr Suman Shirodkar as Chair and Prof Michael Davidson as Non-Executive Member of the Board of Directors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Lucia faccioMichaelh davidsonSuman shirodkarCambridge epigenetixMedicines companyBristol myers squibbOmthera pharmaceuticalsUniversity of chicagoMckinsey coMichael davidsonNon executive memberLarkspur biosciencesLipid clinicSofinnova partnersChief executive officerNew amsterdam pharma

ROSE2: Obicetrapib/ezetimibe combination further lowers LDL in statin-treated patients

In statin-treated patients with dyslipidemia, the combination of obicetrapib and ezetimibe further lowered LDL, according to the results of the phase 2 ROSE2 trial. As Healio previously reported, obicetrapib (NewAmsterdam Pharma), an investigational cholesteryl ester transfer protein (CETP) inhibitor, decreased LDL, non-HDL, lipoprotein(a) and apolipoprotein B and increased HDL at 8 weeks in

Newamsterdam pharmaMichaelh davidsonRichard smithByerik swainLipid clinic at university of chicago medicineNational lipid association scientific sessionsClinical lipidologyCardiology today editorial board member michaelLipid clinicChicago medicine

Uptake Uncertain for Potent New Cholesterol-Lowerer Inclisiran

Inclisiran, a novel small interfering RNA drug that inhibits PCSK9, made its US debut in early 2022 with cautious uptake prospects.

Rocky mountainUnited statesNorthwestern universityUniversity of chicagoBaylor college of medicineMichaele debakeyPaull hessRoberth eckelColl cardiolVijay nambiChristiem ballantyneMichaelh davidsonChandni bardoliaAmerican heart associationAmerican college of cardiologyDrug administration

Abcentra Appoints Entrepreneur and Cardiologist Michael H Davidson to Board of Directors

/PRNewswire/ Abcentra LLC announced today that Michael H. Davidson, MD, has been appointed to the Board of Directors. Dr. Davidson is currently CEO of New.

United statesNorthwestern universityJohn farinaLos angelesAstra zenecaMichaelh davidsonOmthera pharmaceuticalsChicago centerNational lipid associationUniversity of chicago pritzker school medicineProduct developmentClinical researchOhio state university school of medicineNew amsterdam pharmaChief medical officerCorvidia therapeutics